Bär & Karrer advises Miele o the Establishment of a Joint Venture in the Fields of Infection Control and Life Science Miele and Metall Zug have reached an agreement outlining the establishment of a
Tags :Linus Zweifel
Highlight Event and Entertainment, which is listed on the SIX Swiss Exchange, has completed a rights offering with net proceeds of CHF 41.2 million. The new shares were subscribed by or placed with existing shareholders, several
Novartis has completed the spin-off of Sandoz‘s generics and biosimilars business, with the result that Sandoz Group debuted as an independent, publicly traded company. Sandoz shares were successfully listed on the Swiss stock exchange,
ELANTAS, a subsidiary of the specialty German chemicals group ALTANA, entered into a share purchase agreement with the von Finck family and tender agreements with the von Roll management pursuant to which ELANTAS will acquire
Quaestor Coach, an independent private equity group specializing in a buy-and-build in discretionary wealth management, announced that Investarit, a Zurich-based international wealth management boutique and partner for comprehensive asset management services, joins forces with Diem
Swiss Allwyn Entertainment (former Sazka Entertainment), a multinational lottery operator operating lotteries in Austria, the Czech Republic, Greece, Cyprus and Italy, intends to become a publicly-listed company on the NYSE in partnership with Cohn Robbins
Quaestor Coach, an independent private equity group specialising in a buy-and-build in discretionary wealth management, has entered the Swiss market and has acquired Diem Client Partner, a Zurich-based independent wealth management boutique for high-net-worth individuals
UBS has signed an agreement to sell UBS Swiss Financial Advisers (UBS SFA) to Vontobel, a global investment firm. UBS SFA is a Swiss-based SEC-registered investment advisor and FINMA-licensed securities firm for US clients seeking
AC Immune, a clinical-stage biopharmaceutical precision medicine company for neurodegenerative diseases, announced it’s acquisition of Affiris’s portfolio of therapeutics targeting alphasynuclein (a-syn), notably Affiris PD01, a clinically-validated active vaccine candidate for the treatment
The shareholder of Odlo has completed the sale of Swiss-based ODLO International and its subsidiaries to Monte Rosa Sports Holding.
